El mercado de medicamentos de venta libre y suplementos dietéticos se valoró en 2.93.255,40 millones de dólares en 2019 y se prevé que alcance los 4.92.102,49 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 6,8% de 2020 a 2027.
Los medicamentos de venta libre (OTC) están disponibles para el público para su uso general. Estos medicamentos no requieren receta médica. Los medicamentos de venta libre están disponibles para diversos fines médicos. afecciones como tos y resfriados, diarrea, acidez de estómago, estreñimiento, acné, dolor y otros. Por otro lado, los suplementos dietéticos están disponibles sin receta para fines de fitness. Sin embargo, la compra de un suplemento dietético con ingredientes medicinales requiere receta médica cuando una persona está gravemente enferma o requiere tratamiento. Estos medicamentos de venta libre y suplementos nutricionales tienen dos formas: de marca o genéricos.
El alcance del mercado de suplementos dietéticos y medicamentos de venta libre incluye producto, tipo, forma, canal de distribución y región. El mercado de medicamentos de venta libre y suplementos dietéticos se analiza en regiones como América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y América del Sur y Central. El informe ofrece información y un análisis en profundidad del mercado de suplementos dietéticos y medicamentos de venta libre haciendo hincapié en varios parámetros, como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis del panorama competitivo de los principales actores del mercado en todo el mundo.
Perspectivas estratégicas
regiones lucrativas para el mercado de suplementos dietéticos y medicamentos de venta librePerspectivas del mercado
Creciente conciencia sobre los problemas de salud general
Hoy en día, la gente es muy consciente de los problemas de salud generales, como el resfriado, la tos, las alergias, la fiebre, el dolor, la acidez, la diarrea y las afecciones relacionadas con la piel. La mayoría de la población se centra en tener un estilo de vida saludable evitando el consumo de comida chatarra, lo que conduce a un aumento de enfermedades relacionadas con el estilo de vida, como diabetes, obesidad y enfermedades cardiovasculares. La creciente preferencia por mantener un estilo de vida saludable también conduce al consumo de productos para bajar de peso y suplementos dietéticos, como vitaminas, minerales y suplementos. El aumento de la exposición a Internet ha llevado a un mayor acceso a suplementos dietéticos y medicamentos de venta libre para los consumidores, a precios asequibles.
Los problemas de salud comunes pueden ser estacionales o pueden ocurrir debido a cambios menores en los hábitos de rutina; por lo tanto, las personas prefieren tomar medicamentos de venta libre para tratarlos en lugar de visitar a un médico. En muchos casos, esto ahorra tiempo y dinero y proporciona un alivio inmediato. Varios gobiernos han iniciado diversos programas de concientización sobre la salud, gracias a los cuales se ha producido una adopción rápida y fluida de tecnología cotidiana para la atención médica y el bienestar, lo que contribuye al crecimiento general de la industria. Por ejemplo, en India, el gobierno está tomando medidas positivas para formalizar el uso de medicamentos de venta libre. Los programas de seguimiento de recetas (PMP) recopilan, monitorean y analizan datos de prescripción y dispensación transmitidos electrónicamente y presentados por farmacias y profesionales de dispensación. Estos datos luego se utilizan para prevenir el abuso de medicamentos de venta libre. Promoviendo así la venta de medicamentos de venta libre.
Los avances en la industria farmacéutica, como los modelos predictivos, las aplicaciones móviles, la robótica y el diagnóstico, están abriendo nuevas vías para los farmacéuticos. , lo que puede mejorar su capacidad para dispensar medicamentos, minimizar errores y monitorear la adherencia del paciente. Los medicamentos dispensados correctamente no darán lugar a ningún tipo de abuso de drogas, lo que genera aún más confianza en la recompra de productos de venta libre y suplementos dietéticos. Por lo tanto, la conciencia de los problemas de salud generales y los avances en la industria farmacéutica están impulsando el crecimiento del mercado.
&n bsp;
Información basada en productos sobre medicamentos de venta libre y suplementos dietéticos ; < /p>
Según el producto, el mercado de medicamentos de venta libre y suplementos dietéticos se segmenta en productos para la tos y el resfriado, vitaminas y suplementos dietéticos, analgésicos, productos gastrointestinales, somníferos, productos para el cuidado bucal, productos oftálmicos, antiácidos, cuidado femenino, y otros.
En 2019, el segmento de analgésicos representó la mayor participación del mercado. El crecimiento de este segmento se atribuye a la creciente conciencia sobre los problemas de salud general y la creciente preferencia por los medicamentos sin receta sobre los medicamentos con receta en todo el mundo. Sin embargo, es probable que el segmento de vitaminas y suplementos dietéticos registre la CAGR más alta en el mercado mundial de suplementos dietéticos y medicamentos de venta libre durante el período de pronóstico.
&n bsp; &n bsp; &n bsp;
Mercado global de medicamentos de venta libre y suplementos dietéticos, por tipo de medicamentos de venta libre y suplementos dietéticos: 2019 y 2019 2027Información basada en el tipo
Según el tipo, el mercado de suplementos dietéticos y medicamentos de venta libre se segmenta en de marca y genéricos. El segmento de genéricos tuvo una mayor participación del mercado en 2019; mientras que se estima que el mismo segmento registrará una CAGR más alta del 7,1% en el mercado durante el período previsto.
Información basada en la forma
Según la forma, el mercado de suplementos dietéticos y medicamentos de venta libre se segmenta en tabletas, cápsulas, polvos, ungüentos y líquidos. , y otros. El segmento de tabletas tuvo la mayor participación del mercado en 2019 y se estima que registrará la CAGR más alta del mercado del 7,5 % durante el período de pronóstico.
; ;
Basado en el canal de distribución, el mercado de suplementos dietéticos y medicamentos de venta libre se segmenta en farmacias hospitalarias y minoristas, tiendas minoristas, canales online, y otros. El segmento de farmacias hospitalarias y minoristas tuvo la mayor participación del mercado en 2019; sin embargo, se estima que el segmento de canales en línea registrará la CAGR más alta del mercado del 7,5% durante el período de pronóstico.
; ;
Lanzamientos y expansión de productos Las empresas suelen adoptar estrategias para ampliar su presencia y cartera de productos en todo el mundo, así como para satisfacer la creciente demanda.
Los actores del mercado que operan en el mercado de medicamentos de venta libre y suplementos dietéticos adoptaron la estrategia de innovación de productos para satisfacer la demanda cambiante de los clientes en todo el mundo, lo que también permite a los jugadores mantener su marca a nivel mundial.
Por producto
< ul>
Por tipo ;
- De marca
- Genérico
Por forma
- Tabletas
- Cápsulas
- Polvos
- Pomadas
- Líquidas
- Otras
Por canal de distribución
- Hospital y Farmacias minoristas
- Tiendas minoristas
- Canales online
- Otros
Por geografía
- América del Norte
- Estados Unidos
- Canadá
- México
- Europa
- Francia
- Alemania
- Italia
- Reino Unido
- España
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Medio Oriente y Asia África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- América del Sur (SAM)< ul>
- Brasil
- Argentina
Perfiles de empresas
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The use of OTC drugs to treat various health conditions has allowed saving healthcare expenditure. Also, the consumption of dietary supplements has helped in improving health and enhance immunity. Thus, the products have provided affordable treatment options for both consumers and the healthcare systems across the globe.
The growth of the market is attributed to growing awareness regarding general health issues and growing preference for non-prescription drugs over prescription drugs. However, the stringent FDA regulations related to safety and efficacy of OTC drugs is expected to hinder the market growth.
Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two forms, such as branded or generic.
The List of Companies - OTC Drug and Dietary Supplement Market
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)